Connor, Clark & Lunn Investment Management (CC&L)
CLPT icon

Connor, Clark & Lunn Investment Management (CC&L)’s ClearPoint Neuro CLPT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,396
Closed -$329K – 1434
2024
Q4 		$329K Sell
21,396
-11,265
-34% -$146K ﹤0.01% 1242
2024
Q3 		$366K Buy
+32,661
New +$313K ﹤0.01% 1182

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CLPT Position: Q1 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of ClearPoint Neuro (CLPT) in Q1 2025, closing a stake of 21,396 shares — an estimated $329K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CLPT in Q3 2024 and held it in 2 quarters. The position peaked at $366K in Q3 2024. 101 funds tracked by Wall St. Rank hold CLPT as of Q1 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining ClearPoint Neuro position as of Q1 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 21,396 ClearPoint Neuro shares in Q1 2025, an estimated $329K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ClearPoint Neuro in Q3 2024 and held it in 2 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ClearPoint Neuro position peaked at $366K in Q3 2024.
  • 101 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.